Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum complement and familial combined hyperlipidemia

K Ylitalo1, K V Porkka, S Meri

  • 1Department of Medicine, University of Helsinki, Finland.

Atherosclerosis
|March 21, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of transcatheter atrial septal defect closure in a nationwide cohort.

Annals of medicine·2023
Same author

Young adults' human papillomavirus-related knowledge: source of medical information matters.

Public health·2020
Same author

Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.

European journal of neurology·2017
Same author

Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

European journal of neurology·2015
Same author

Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score.

Genes, brain, and behavior·2012
Same journal

Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia.

Atherosclerosis·2026
Same journal

Causal insights of modifiable cardiovascular risk factors for dementia risk - potential for efficient prevention and improved brain health.

Atherosclerosis·2026
Same journal

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same journal

Earliest age to detect lifetime cardiometabolic health stratification in children.

Atherosclerosis·2026
Same journal

Sympathetic neurons exacerbate atherosclerosis by modulating macrophage function via the NPY/Y1R axis.

Atherosclerosis·2026
Same journal

Optimizing lipoprotein(a) testing for immediate clinical impact in primary prevention.

Atherosclerosis·2026
See all related articles

Familial combined hyperlipidemia (FCHL) is linked to higher levels of complement C3. This suggests a potential role for the complement system in FCHL

Area of Science:

  • Biochemistry
  • Genetics
  • Immunology

Background:

  • Familial combined hyperlipidemia (FCHL) is a common inherited lipid disorder.
  • Acylation stimulating protein (ASP) resistance in adipocytes may impair triglyceride synthesis, leading to postprandial lipemia in FCHL.
  • ASP is identical to C3a-desArg, a fragment of the complement component C3.

Purpose of the Study:

  • To investigate the relationship between serum complement components C3 and C4 levels and lipid/glucose metabolism markers in FCHL families.
  • To explore the potential role of the complement system in the pathogenesis of FCHL.

Main Methods:

  • Analysis of serum levels of complement components C3 and C4.
  • Assessment of lipid and glucose metabolism markers.
  • Study conducted in 11 large FCHL families (n=53).

Related Experiment Videos

Main Results:

  • Median serum C3 levels were significantly higher (38%) in affected male FCHL family members compared to non-affected males.
  • Strong correlations were found between serum complement C3 and apolipoprotein B levels (r=0.77 in males).
  • These associations were independent of obesity and impaired glucose tolerance.

Conclusions:

  • Serum levels of complement components C3 and C4 significantly correlate with serum lipid levels in FCHL.
  • Further research is necessary to elucidate the role of complement system disturbances in FCHL pathogenesis.
  • Findings suggest a potential link between complement activation and lipid metabolism abnormalities in FCHL.